PROGNOSTIC IMPACT OF GENDER IN NEWLY DIAGNOSED MCL IS ASSOCIATED WITH HIGHER PREVALENCE OF ADVERSE GENETIC EVENTS IN MALES COMPARED TO FEMALES

EHA Library, Diana Malarikova, 420152

FAVEZELIMAB (ANTI-LAG-3) PLUS PEMBROLIZUMAB (PEMBRO) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) INDOLENT NON-HODGKIN LYMPHOMA: COHORT 4 OF A MULTICOHORT OPEN-LABEL PHASE 1/2 STUDY

EHA Library, David Lavie, 420153

CLINICAL MANIFESTATIONS OF 35 NK CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA

EHA Library, Zhe Zhuang, 420154

IMPACT OF EARLY RELAPSE (POD24) & P53 ALTERATIONS ON TREATMENT OUTCOMES IN PATIENTS WITH MCL, MULTI-CENTRE, RETROSPECTIVE COHORT STUDY IN IRELAND.

EHA Library, Ezzat Elhassadi, 420155

THE SAFETY AND EFFICACY OF OBINUTUZUMAB PLUS CHEMOTHERAPY THERAPY FOR UNTREATED FOLLICULAR LYMPHOMA: A CHINESE RETROSPECTIVE ANALYSIS

EHA Library, Zheng Song, 420156

DOSE ADJUSTMENT OUTCOMES IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA TREATED WITH IBRUTINIB

EHA Library, Shayna Sarosiek, 420157

THE EFFICACY AND SAFETY OF OBINUTUZUMAB WITH ZANUBRUTINIB AS FIRST-LINE TREATMENT IN OLDER PATIENTS WITH MANTLE CELL LYMPHOMA

EHA Library, Yanan Zhu, 420158

IMPACT OF VACCINATION AND CURRENT IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA PATIENTS WITH COVID-19

EHA Library, Mengyuan He, 420159

EVALUATION OF ANEMIA IN NEWLY DIAGNOSED PATIENTS WITH MALIGNANT LYMPHOMAS

EHA Library, Nina Petkova, 420160

ORELABRUTINIB IN PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL) INTOLERANT TO PRIOR BRUTON TYROSINE KINASE INHIBITORS (BTKI): PRELIMINARY RESULTS FROM A PHASE 2 STUDY

EHA Library, Li Wang, 420161

GLOFITAMAB MONOTHERAPY RETREATMENT IN PATIENTS WITH HEAVILY PRETREATED RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA: RESULTS FROM A PHASE I/II STUDY

EHA Library, Emmanuel Bachy, 420162

POLATUZUMAB VEDOTIN, ZANUBRUTINIB AND RITUXIMAB (POLA-ZR) ACHIEVED RAPID AND DEEP RESPONSE IN PREVIOUSLY UNTREATED FRAIL AND ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: UPDATED FOLLOW-UP

EHA Library, Yuhong Ren, 420163

OUTCOMES OF PATIENTS WITH PRIMARY CNS LYMPHOMA TREATED WITH MATRIX CHEMOIMMUNOTHERAPY FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT – A MULTICENTRE, RETROSPECTIVE STUDY

EHA Library, Adam Suleman, 420164

SIX VS. EIGHT DOSES OF RITUXIMAB IN COMBINATION WITH SIX CYCLES OF CHOP IN PATIENTS WITH NEWLY DIAGNOSED DLBCL

EHA Library, Yoshimasa Kamoda, 420165

CLINICAL AND MOLECULAR CHARACTERISTICS OF PATIENTS WITH DOUBLE/TRIPLE HIT DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Yi-ge Shen, 420166

PHASE II STUDY OF EZH2 INHIBITOR TAZEMETOSTAT PLUS AMDIZALISIB, A PI3K INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMAS

EHA Library, Mingci Cai, 420167

LOGISTICAL CHALLENGES ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY (CAR T) IN NON-HODGKIN LYMPHOMA (NHL): A SURVEY OF HEALTHCARE PROFESSIONALS

EHA Library, Anna Sureda Balari, 420168

COMPARISON OF NCCN-IPI VERSUS IPI AS PART OF TRIAL ELIGIBILITY CRITERIA FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jelena Jelicic, 420169

THE EFFICACY AND SAFETY OF BRIDGING CAR-T THERAPY WITH HYPER-FRACTIONATED RADIOTHERAPY IN THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jing Ruan, 420170

CLINICAL APPLICATION OF AN EX-VIVO PLATFORM TO GUIDE PERSONALIZED SALVAGE THERAPY IN RELAPSED/REFRACTORY MATURED T-CELL AND NK-CELL LYMPHOMAS

EHA Library, Daryl Tan, 420171

NOVEL TARGETED AGENTS IN COMBINATION WITH R-ICE (R-ICE-X) BASED ON GENOTYPING IN RELAPSED/REFRACTORY DLBCL

EHA Library, Yi-ge Shen, 420172

EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II TRIAL IN CHINA

EHA Library, Tao yang, 420173

FOLLOW-UP ON PHASE 1 STUDY OF AT101, A NOVEL ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY (CAR-T) IN RELAPSED OR REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA PATIENTS

EHA Library, Dok Hyun Yoon, 420174

REAL-WORLD SAFETY OUTCOMES OF AXICABTAGENE CILOLEUCEL IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA IN EUROPE AND UNITED STATES: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Robin Sanderson, 420175

THIOTEPA AND POMALIDOMIDE COMBINATION THERAPY FOR RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: PRELIMINARY FINDINGS FROM A PHASE Ⅱ STUDY

EHA Library, Haorui Shen, 420176

SERUM EOTAXIN PREDICTS LONG-TERM SURVIVAL OF R/R AGGRESSIVE B-CELL LYMPHOMA PATIENTS RECEIVING CD19 CAR-T THERAPY

EHA Library, Hu Qian, 420177

A PHASE II, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TAFASITAMAB COMBINED WITH LENALIDOMIDE IN PATIENTS WITH RELAPSED/ REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Wenjuan Yu, 420178

COMPLETE RESPONSE AT 6 MONTHS IS ASSOCIATED WITH OVERALL SURVIVAL AFTER 1L CHEMOIMMUNOTHERAPY FOR HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: A POOLED CLINICAL TRIAL ANALYSIS

EHA Library, Ran Reshef, 420179

EPIDEMIOLOGICAL TRENDS AND TREATMENT CHALLENGES OF NON-HODGKIN LYMPHOMA IN ARMENIA: A COMPREHENSIVE RETROSPECTIVE COHORT STUDY

EHA Library, Lusine SAHAKYAN, 420180

GLOFITAMAB EFFICACY, TOLERABILITY, AND PRACTICAL IMPLICATIONS IN THE REAL WORLD: A UK MULTICENTRE, RETROSPECTIVE ANALYSIS.

EHA Library, Kushani Ediriwickrema, 420181

COMBINING BASELINE AND END-OF-TREATMENT QUANTITATIVE PET PARAMETERS TO IMPROVE PROGRESSION-FREE SURVIVAL PREDICTION IN DLBCL

EHA Library, Annelies Bes, 420182

EVALUATING PREDICTORS OF NEW PERSISTENT OPIOID USE IN EARLY SURVIVORSHIP FOR PATIENTS WITH DLBCL

EHA Library, Jessie Peng, 420183

SUBCUTANEOUS CM355, A NOVEL BISPECIFIC CD20/CD3 ANTIBODY SHOWED PROMISING EFFICACY AND FAVORABLE SAFETY PROFILE IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Chen Zhang, 420184

TISLELIZUMAB IN COMBINATION WITH ZANUBRUTINIB AND METHOTREXATE IS AN EFFECTIVE REGIMEN FOR PRIMARY CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Xia Zhao, 420185

BTG1 MUTATION CORRELATES WITH INFERIOR PROGNOSIS IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jin-Hua Liang, 420186

COMBINATION OF VENETOCLAX AND STANDARD PLATINUM-CONTAINING REGIMENS IN THE TREATMENT OF RELAPSES AND RESISTANT COURSE OF B-CELL LYMPHOMAS.

EHA Library, Lev Butaev, 420187

INTENSIVE THERAPY OF AGGRESSIVE B-CELL LYMPHOMAS WITH TP53 GENE MUTATION

EHA Library, Nelli Gabeeva, 420188

IPI 1-2 WITH BULKY DISEASE AND/OR VERY HIGH LDH IS A HIGH-RISK SUBGROUP OF UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A HELLENIC DATABASE VALIDATION OF THE LEO COHORT

EHA Library, Theodoros Vassilakopoulos, 420189

VENETOCLAX AND BTK INHIBITORS BASED CHEMOTHERAPY IS A POTENTIAL EFFECTIVE CAR-T BRIDGING THERAPY IN R/R B-NHL

EHA Library, Liu Rui, 420190

INTENSIFIED R-CODOX-M/IVAC THERAPY FOR BIOLOGICALLY UNFAVOURABLE DIFFUSE LARGE B-CELL LYMPHOMA: EFFICACY, TOXICITY, AND CNS RELAPSE PREVENTION

EHA Library, Morgana Schirru, 420191

CHIDAMIDE WITH AZACITIDINE AND CHOP TREATMENT PLUS AUTO-ASCT FOR PATIENTS WITH NEWLY DIAGNOSED PERIPHERAL T-CELL LYMPHOMA:INTERIM ANALYSIS OF A PROSPECTIVE,SINGLE CENTER,SINGLE-ARM, PHASE 2 TRIAL

EHA Library, Chunyan Xiao, 420193

THE PREDICTIVE ROLE OF FIRST-LINE TREATMENT INTERIM PET IN PERIPHERAL T-CELL LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Nicolò Rampi, 420194

COMPREHENSIVE GERIATRIC ASSESSMENT AS A PROGNOSTIC FACTOR FOR THE OUTCOME OF R-CHOP TREATMENT IN ELDERLY PATIENTS WITH AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMAS

EHA Library, Paula Jabłonowska-Babij, 420195

GEOGRAPHIC AND DEMOGRAPHIC DISTRIBUTION OF T-CELL AND NK-CELL LYMPHOMA ENTITIES IN PERU

EHA Library, Daniel Enriquez-Vera, 420196

BRUTON TYROSINE KINASE INHIBITORS AND CHIDAMIDE-COMBINED THERAPY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Ping Li, 420197

CLINICAL AND RADIOLOGICAL FEATURES OF NEUROLOGICAL INVOLVEMENT IN INTRAVASCULAR LARGE B-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Yi-ao Di, 420198

TISLELIZUMAB IN COMBINATION WITH GEMCITABINE, PEGASPARGAS, AND ETOPOSIDE (PPGE) IN PATIENTS WITH PRIMARY NK/T-CELL LYMPHOMA: A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY

EHA Library, Chen Liu, 420199

PATHOGENIC GERMLINE CHEK2 VARIANTS IN LYMPHOID AND MYELOID NEOPLASMS

EHA Library, Adriana Oñós Clausell, 420200

CLINICAL FEATURES AND PROGNOSTIC FACTORS OF ADULT SYSTEMIC CHRONIC ACTIVE EPSTEIN-BARR VIRUS DISEASE: A RETROSPECTIVE ANALYSIS USING JAPANESE REGISTRY DATA

EHA Library, AIKA FUSEYA, 420201

EXPLORING THE PROGNOSTIC PERFORMANCE OF CIRCSCORE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

EHA Library, Ruth Salim, 420202

IDENTIFYING SOMATIC MUTATIONS IN AGGRESSIVE NON-HODGKIN B-CELL LYMPHOMA WITH ENHANCED SPECIFICITY USING LIQUID BIOPSY: A COMPARATIVE STUDY OF CELL-FREE DNA AND FFPE TISSUE

EHA Library, Gayaththri Vimalathas, 420203

FUNCTIONAL APOPTOSIS PROFILING REVEALS VULNERABILITIES IN T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA

EHA Library, Paolo Mazzeo, 420204

SINGLE-CELL RNA SEQUENCING REVEALS MALIGNANT B CELL AND T CELL EXHAUSTION IN AIDS-RELATED DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Zailin Yang, 420205

POTENTIAL DIAGNOSTIC AND PROGNOSTIC BIOMARKERS OF PEDIATRIC BURKITT LYMPHOMA IDENTIFIED THROUGH MIRNA-SEQ OF TUMOR TISSUE AND PLASMA

EHA Library, Can Küçük, 420206

DRUG PROFILING IN A PRECLINICAL MURINE MANTLE CELL LYMPHOMA MOUSE MODEL IDENTIFIES NOVEL VULNERABILITIES

EHA Library, Luca Pagliaro, 420207

DECIPHERING THE BCR REPERTOIRE VIA 5′ RAPID AMPLIFICATION OF CDNA ENDS (5′RACE) IDENTIFIES PRIMARY MEDIASTINAL B-CELL LYMPHOMA CASES WITH HIGH TUMOR DENSITY AND POORER OUTCOMES

EHA Library, Vincent Camus, 420208

NON-CODING RNAS DRIVE IBRUTINIB RESISTANCE IN MANTLE CELL LYMPHOMA VIA THE AKT/PI3K AND MAPK PATHWAYS

EHA Library, Oshrat Hershkovitz-Rokah, 420209

RARE BUT SPECIFIC B-CELL RECEPTOR REACTIVITIES AGAINST COXSACKIEVIRUS A24 IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS

EHA Library, Igor Age Kos, 420210

INHIBITION OF NUCLEAR EXPORT PROMOTES EXPANDED NK CELL AND ANTI-CD19 CAR NK CELL LYSIS OF MALIGNANT B CELLS VIA DISRUPTION OF NKG2A

EHA Library, Jack Fisher, 420211

HISTONE LACTYLATION OF SFXN1 PROMOTER FACILITATES ONE-CARBON PATHWAY IN T-CELL LYMPHOMA

EHA Library, Xin Wang, 420212

GENOMIC PROFILING AND TRACKING OF CLASSICAL HODGKIN LYMPHOMA USING CELL-FREE DNA

EHA Library, Nick Veltmaat, 420213

RELATIONSHIP BETWEEN 18F-FDG PET/CT AND BIOLOGICAL CHARACTERIZATION OF PATIENTS WITH NON-HODGKIN LYMPHOMA UNDERGOING CAR THERAPY.

EHA Library, Luzalba Sanoja-Flores, 420214

ANTI-PROLIFERATIVE EFFICACY AND IMMUNOGENIC POTENTIAL OF BRINCIDOFOVIR IN PERIPHERAL T-CELL LYMPHOMA

EHA Library, Boon Yee Lim, 420215

PLASMA CTDNA MINIMAL RESIDUAL DISEASE FROM IG REARRANGEMENT PREDICTS TREATMENT OUTCOMES IN PATIENTS WITH DLBCL: EARLY RESULTS FROM MEDIG STUDY.

EHA Library, Xiao Liu, 420216

NOVEL TERBIUM-161 RADIOIMMUNOTHERAPY AS AN INNOVATIVE TREATMENT FOR CD30+ LYMPHOMAS

EHA Library, Elisa Rioja Blanco, 420217

BAICALIN REGULATES THE RATIO OF TH2/TH1 CELLS TO TREAT INTESTINAL ACUTE GRAFT VERSUS HOST DISEASE

EHA Library, Xing Cui, 420218

PAEONIFLORIN ALLEVIATES ACUTE GRAFT-VERSUS-HOST DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION BY INHIBITING CD8+ T CELL CYTOTOXICITY

EHA Library, Xingyu Wan, 420219

CLINICAL ANALYSIS OF THE THERAPEUTIC EFFECT OF UMBILICAL CORD BLOOD STEM CELL TRANSPLANTATION IN 5 CASES OF MUCOPOLYSACCHARIDOSIS TYPE II

EHA Library, qi ji, 420220

RISK OF ACUTE KIDNEY INJURY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY

EHA Library, Ping-Chi Tsai, 420221

ANTI-PD-1, HYPOMETHYLATING AGENT FOLLOWED BY CAG REGIMEN BRIDGING TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PROMISING NOVEL STRATEGY FOR RELAPSED/ REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Dai-Hong Liu, 420223

TWO NOVEL MUTATIONS IN PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY AND CLINICAL OUTCOME AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM AN HLA-MATCHED UNRELATED DONOR: A PEDIATRIC CASE REPORT

EHA Library, Minyuan Liu, 420224

THERAPEUTIC DRUG MONITORING OF ANTI-THYMOCYTE GLOBULIN IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANTATION: A PROSPECTIVE STUDY TO PREVENT GRAFT-VERSUS-HOST DISEASE AND PRIMARY DISEASE RECURRENCE.

EHA Library, Natalia Maximova, 420226

ORAL CRYOTHERAPY BY KANGFUXIN FOR PROPHYLAXIS OF ORAL MUCOSITIS IN PATIENTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Dan Chen, 420227

AUTOIMMUNE DISORDER HISTORY AS A MORE ADVANCED RISK FACTOR FOR PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA RECEIVING AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Fei Zhao, 420228

MONOCYTE RECONSTITUTION AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Nour Ben Abdeljelil, 420229

COMBINATION OF CHEMOTHERAPY AND MECAPEGFILGRASTIM FOR HEMATOPOIETIC STEM CELL MOBILIZATION IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS: A PROSPECTIVE, OPEN-LABEL, RANDOMIZED STUDY

EHA Library, Wei Liu, 420230

POST TRANSPLANT CYCLOPHOSPHAMIDE CARDIOTOXICITY RISK PREDICTION IN HAPLOIDENTICAL ALLOGENEIC TRANSPLANT

EHA Library, Daiana Rodriguez, 420231

CYCLOPHOSPHAMIDE-CONTAINING GVHD PROPHYLAXIS FOR RECIPIENTS OF UNRELATED DONOR HSCT IMPROVES GVHD-FREE, DISEASE-FREE OUTCOME IN PEDIATRIC PATIENTS WITH HEMOGLOBINOPATHIES

EHA Library, Maximilian Hartmann, 420232

THE IMPACT OF PRE-TRANSPLANT IRON PARAMETERS ON ALLOGENEIC HEMATOPOETIC STEM CELL TRANSPLANTATION RELATED SURVIVAL PARAMETERS

EHA Library, Rana Ozince, 420233

LONG-TERM SURVIVAL ANALYSIS OF PRIMARY IMMUNODEFICIENCY DISORDERS, FROM A LOW-MIDDLE INCOME COUNTRY.

EHA Library, Waseem Ahmed, 420234

A COMPARATIVE STUDY OF PERIPHERAL BLOOD STEM CELL VS BONE MARROW TRANSPLANT FROM MATCHED SIBLING DONORS: A SINGLE CENTER STUDY

EHA Library, Nour Ben Adejlil, 420235

STEM CELL MOBILIZATION USING INTERMEDIATE DOSE CYTARABINE + G-CSF IS MORE EFFECTIVE THAN PLERIXAFOR + G-CSF IN POOR MOBILIZERS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Svetlana Elkhova, 420236

ROLE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIMARY CNS LYMPHOMA:  REAL-WORLD DATA FROM A RETROSPECTIVE MULTI CENTRE ANALYSIS

EHA Library, Poon Michelle, 420237

CYTOMEGALOVIRUS MANAGEMENT CHALLENGES IN PATIENTS UNDDERGOING ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: LESSONS FROM A LOW- AND MIDDLE-INCOME COUNTRY

EHA Library, Santiago Riviello Goya, 420238

CMV REACTIVATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION : A SINGLE CENTER EXPERIENCE

EHA Library, Nour Ben Adejlil, 420239

ALLOGENEIC TRANSPLANTATION OF MESENCHYMAL STEM CELLS IN THE SECOND LINE OF THERAPY FOR ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Oksana Nechay, 420240

RISK FACTORS AND IMPACT OF ACUTE GVHD ON OUTCOMES POST ALLOGENIC HCT IN HEMATOLOGICAL MALIGNANCIES : EXPERIENCE OF NATIONAL BONE MARROW TRANSPLANT CENTER OF TUNISIA

EHA Library, Ines Turki, 420241

R-DHAP PLUS PLERIXAFOR “JUST IN TIME” TO MOBILIZE LARGE NUMBERS OF HEMATOPOIETIC STEM CELLS IN RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMAS

EHA Library, Francesco Gaudio, 420242

LONG TERM FOLLOW UP (7 YEARS) OUTCOME OF BONE MARROW DERIVED STEM CELLS IN ACUTE COMPLETE SPINAL CORD INJURY- A RANDOMIZED PLACEBO CONTROLLED TRIAL

EHA Library, Renu Rani, 420243

MISMATCHED UNRELATED DONORS ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH ANTITHYMOCYTE GLOBULIN FOR HEMATOLOGICAL MALIGNANCIES: A MULTICENTER RETROSPECTIVE STUDY IN CHINA

EHA Library, Yi Luo, 420244

KANGFUXIN-BASED CRYOTHERAPY DEMONSTRATED A SIGNIFICANT PROTECTIVE EFFECT ON ORAL MUCOSITIS IN MYELOMA PATIENTS UNDERGOING ASCT WITH MELPHALAN HYDROCHLORIDE AS CONDITIONING REGIMEN

EHA Library, Li Wang, 420245

THE EFFECT OF OUTPATIENT PICC WITH INTELLIGENT THROMBOSIS PREVENTION AND CONTROL PLATFORM IN PREDICTING VENOUS CATHETER THROMBOSIS IN PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hengrui Sun, 420246

PRECONDITIONING ABSOLUTE LYMPHOCYTE COUNT AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Nour Ben Abdeljelil, 420247

CONDITIONING REGIMEN DOSE REDUCTION IN PATIENTS WITH LYMPHOMAS IN THE  AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION SETTINGS

EHA Library, Polina Kotselyabina, 420248

PROGNOSTIC FACTORS AND OUTCOMES OF ADENOVIRUS INFECTION FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jiaxin Zhang, 420249

ANALYSIS OF HAND GRIP STRENGTH IN HEMATOPOIETIC RECONSTRUCTION STAGE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Fangfang Wu, 420250

TO EXPLORE THE CLINICAL EFFECT OF ORAL CRYOTHERAPY AND HELIUM-NEON LASER (HE-NE) ON PROPHYLAXIS OF SEVERE ORAL MUCOSITIS ASSOCIATED WITH CHEMOTHERAPY

EHA Library, Yang He, 420251

PROGNOSTIC NUTRITIONAL INDEX (PNI) AND ITS IMPACT ON THE PROGNOSIS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS: A RETROSPECTIVE COHORT STUDY IN CHINA

EHA Library, Jie Tang, 420252

THE BILE ACID RECEPTOR TGR5 REGULATES THE HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW NICHE

EHA Library, Alejandro Alonso Calleja, 420253

THE ASSOCIATION BETWEEN PLASMA ERYTHROPOIETIN LEVELS AND CLONAL HEMATOPOIESIS RISK: A TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY

EHA Library, George Richenberg, 420254